Yaohui He
Fujian Provincial Key Laboratory Of Innovative Drug Target Research
Xiamen, 361102, China
Xiamen, 361102, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Corrigendum to "piR-36249 and DHX36 together inhibit testicular cancer cells progression by upregulating OAS2" [Noncoding RNA Research 2023 8 (2) 174-186].
Journal: Non-coding RNA research
Published: March 24, 2025
The FBXW7-KMT2 axis in cancer-associated fibroblasts controls tumor growth via an epigenetic-paracrine mechanism.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 24, 2025
Stabilization of AFF1 by PARylation ensures transcriptional restart after DNA damage.
Journal: Nature chemical biology
Published: February 25, 2025
PRMT1 oligomerization regulates RNA-binding protein cascade to promote pancreatic cancer.
Journal: Life science alliance
Published: January 04, 2025
Targeting PRMT7-mediated monomethylation of MAVS enhances antiviral innate immune responses and inhibits RNA virus replication.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 15, 2024
Discovery of 4-(2-(methylamino)thiazol-5-yl)pyrimidin-2-amine derivatives as novel cyclin-dependent kinase 12 (CDK12) inhibitors for the treatment of esophageal squamous cell carcinoma.
Journal: Bioorganic chemistry
Published: November 10, 2024
SARS-CoV-2 membrane protein induces neurodegeneration via affecting Golgi-mitochondria interaction.
Journal: Translational neurodegeneration
Published: May 25, 2024
Quantitative Proteomics of the CDK9 Interactome Reveals a Function of the HSP90-CDC37-P-TEFb Complex for BETi-Induced HIV-1 Latency Reactivation.
Journal: Journal of proteome research
Published: August 04, 2023
piR-36249 and DHX36 together inhibit testicular cancer cells progression by upregulating OAS2.
Journal: Non-coding RNA research
Published: November 10, 2022
eIF3 mRNA selectivity profiling reveals eIF3k as a cancer-relevant regulator of ribosome content.
Journal: The EMBO journal
Published: August 16, 2022
CDK1 Promotes Epithelial-Mesenchymal Transition and Migration of Head and Neck Squamous Carcinoma Cells by Repressing ∆Np63α-Mediated Transcriptional Regulation.
Journal: International journal of molecular sciences
Published: June 11, 2022
Last Updated: 09/26/2026